[Group B streptococcus and high level resistance to aminoglycosides: therapeutic implications for neonates].
Mariani-Kurkdjian
P
P
Benayoun
E
E
Bingen
E
E
Aujard
Y
Y
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D015995:Prevalence; D013290:Streptococcal Infections / Q000188:drug therapy*; D013292:Streptococcus agalactiae / Q000187:drug effects* / Q000472:pathogenicity*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents